These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29604372)

  • 1. Pegylated nanoparticles for the oral delivery of nimodipine: Pharmacokinetics and effect on the anxiety and cognition in mice.
    Moreno LCGEAI; Solas M; Martínez-Ohárriz MC; Muñoz E; Santos-Magalhães NS; Ramirez MJ; Irache JM
    Int J Pharm; 2018 May; 543(1-2):245-256. PubMed ID: 29604372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of nimodipine nanocrystals for oral administration.
    Li J; Fu Q; Liu X; Li M; Wang Y
    Arch Pharm Res; 2016 Feb; 39(2):202-212. PubMed ID: 26584914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine.
    Li H; Li H; Wei C; Ke J; Li J; Xu L; Liu H; YangYang ; Li S; Yang M
    Eur J Pharm Sci; 2018 May; 117():321-330. PubMed ID: 29530545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated poly(anhydride) nanoparticles for oral delivery of docetaxel.
    Ruiz-Gatón L; Espuelas S; Larrañeta E; Reviakine I; Yate LA; Irache JM
    Eur J Pharm Sci; 2018 Jun; 118():165-175. PubMed ID: 29597043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies.
    Basalious EB; Shamma RN
    Int J Pharm; 2015 Sep; 493(1-2):347-56. PubMed ID: 26241752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies.
    Fu Q; Sun J; Zhang D; Li M; Wang Y; Ling G; Liu X; Sun Y; Sui X; Luo C; Sun L; Han X; Lian H; Zhu M; Wang S; He Z
    Colloids Surf B Biointerfaces; 2013 Sep; 109():161-6. PubMed ID: 23668980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery.
    Rashed HM; Shamma RN; Basalious EB
    Drug Deliv; 2016 Nov; 24(1):181-187. PubMed ID: 28156162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nimodipine nanocrystals for oral bioavailability improvement: role of mesenteric lymph transport in the oral absorption.
    Fu Q; Sun J; Ai X; Zhang P; Li M; Wang Y; Liu X; Sun Y; Sui X; Sun L; Han X; Zhu M; Zhang Y; Wang S; He Z
    Int J Pharm; 2013 May; 448(1):290-7. PubMed ID: 23384726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease.
    Moreno LCGEI; Puerta E; Suárez-Santiago JE; Santos-Magalhães NS; Ramirez MJ; Irache JM
    Int J Pharm; 2017 Jan; 517(1-2):50-57. PubMed ID: 27915007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between dissolution and bioavailability for nimodipine colloidal dispersions: the critical size in improving bioavailability.
    Fu Q; Kou L; Gong C; Li M; Sun J; Zhang D; Liu M; Sui X; Liu K; Wang S; He Z
    Int J Pharm; 2012 May; 427(2):358-64. PubMed ID: 22370475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution.
    Sun Y; Rui Y; Wenliang Z; Tang X
    Int J Pharm; 2008 Jul; 359(1-2):144-9. PubMed ID: 18499371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-stress effects of cilnidipine and nimodipine in immobilization subjected mice.
    Kumar N; Singh N; Jaggi AS
    Physiol Behav; 2012 Mar; 105(5):1148-55. PubMed ID: 22210395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs.
    Lee JY; Park JH; Lee JJ; Lee SY; Chung SJ; Cho HJ; Kim DD
    Carbohydr Polym; 2016 Oct; 151():68-77. PubMed ID: 27474544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and pharmacokinetics of nimodipine-loaded liposomes.
    Wang Z; Deng Y; Zhang X; Wang T; Wu F
    J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the serotoninergic system in the anxiolytic action mechanism of a liposomal formulation containing nimodipine (NMD-Lipo).
    Viana HKMMC; da Silva Oliveira GL; Moreno LCGEAI; de Melo-Cavalcante AAC; de Moura do Amaral MP; Arcanjo DDR; Rolim HML
    Pharmacol Biochem Behav; 2023 Nov; 232():173654. PubMed ID: 37802395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pore size of three-dimensionally ordered macroporous chitosan-silica matrix on solubility, drug release, and oral bioavailability of loaded-nimodipine.
    Gao Y; Xie Y; Sun H; Zhao Q; Zheng X; Wang S; Jiang T
    Drug Dev Ind Pharm; 2016; 42(3):464-72. PubMed ID: 26507935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
    Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of liposomal formulation containing nimodipine on anxiolytic activity in mice.
    Moreno LC; da Silva Oliveira GZ; Cavalcanti IM; Santos-Magalhães NS; Rolim HM; de Freitas RM
    Pharmacol Biochem Behav; 2014 Jan; 116():64-8. PubMed ID: 24201051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of novel tissue acidosis-responsive chitosan drug nanoparticles: Characterization and in vitro release properties of Ca
    Janovák L; Turcsányi Á; Bozó É; Deák Á; Mérai L; Sebők D; Juhász Á; Csapó E; Abdelghafour MM; Farkas E; Dékány I; Bari F
    Eur J Pharm Sci; 2018 Oct; 123():79-88. PubMed ID: 30026092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain.
    Zhang Q; Jiang X; Jiang W; Lu W; Su L; Shi Z
    Int J Pharm; 2004 May; 275(1-2):85-96. PubMed ID: 15081140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.